Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Much Will The Blood Based Biomarkers Market Be Worth By 2029?

The market size for blood-based biomarkers has seen a substantial increase in the recent past. It is projected to expand from $23.13 billion in 2024 to $25.83 billion in 2025, marking a compound annual growth rate (CAGR) of 11.6%. The remarkable growth over the historical period can be credited to a global surge in cancer cases, the expanding adoption of personalized medicine, a boost in biomarker research funding, the broadening of clinical trials involving biomarkers, and an increase in the approval of companion diagnostics.

The market size of blood-based biomarkers is anticipated to experience swift expansion in the coming years, reaching “$40.66 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.0%. This surge projected in the forecast period is linked to the growth of AI and machine learning in biomarker analysis, a heightened demand for early disease detection, advancement in telemedicine and remote diagnostics, increasing cases of chronic diseases, and an upsurge in consumer health consciousness. Noteworthy trends forecasted for this period include discoveries in AI-guided biomarkers, advancements in liquid biopsy, integration of multi-omics, development of point-of-care (POC) testing devices, and innovations in next-generation sequencing (NGS).

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24176&type=smp

Which Industry Forces Are Driving The Blood Based Biomarkers Market Forward?

The increase in cardiovascular diseases is predicted to drive the expansion of the blood-based biomarkers market. Cardiovascular diseases, which encompass issues pertaining to the heart and blood vessels such as heart failure, coronary artery disease, and stroke, are primarily attributed to the increase in risk factors like poor dietary habits and escalating obesity rates. The utility of blood-based biomarkers lies in their ability to diagnose and track cardiovascular diseases, offering insight into the progression of the disease, risk evaluation, and treatment response through substances detectable in the blood. For example, the National Center for Biotechnology Information, a US-based government body, reported a health research initiative in September 2024 that predicts a 90% surge in cardiovascular disease incidence from 2025 to 2050. It also projected cardiovascular fatalities to touch 35.6 million by 2050. Consequently, the escalation in cardiovascular disease instances is fueling the expansion of the blood-based biomarkers market.

How Is The Global Blood Based Biomarkers Market Broken Down By Segment?

The blood based biomarkers market covered in this report is segmented –

1) By Type: Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Cell-Based Biomarkers, Epigenetic Biomarkers

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Immunoassays, Mass Spectrometry, Other Technologies

3) By Application: Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other Applications

4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:

1) By Genetic Biomarkers: Deoxyribonucleic Acid (DNA) Mutations, Ribonucleic Acid (RNA) Expression Profiles, Single Nucleotide Polymorphisms (SNPs), Copy Number Variations (CNVs), Gene Fusions

2) By Protein Biomarkers: Enzymes, Hormones, Cytokines, Tumor Markers, Acute Phase Proteins

3) By Metabolic Biomarkers: Lipid Profiles, Amino Acid Levels, Glucose And Lactate Levels, Organic Acids, Metabolite Panels

4) By Cell-Based Biomarkers: Circulating Tumor Cells (CTCs), Immune Cell Profiling, Stem Cells, Platelets, Endothelial Cells

5) By Epigenetic Biomarkers: Deoxyribonucleic Acid (DNA) Methylation Patterns, Histone Modifications, Non-Coding Ribonucleic Acid (RNA), Chromatin Accessibility, Epigenetic Enzyme Activity

Which Trends Are Likely To Redefine Growth Paths In The Blood Based Biomarkers Market?

In an effort to improve Alzheimer’s disease diagnosis, major corporations in the blood-based biomarkers sector are prioritizing advancements in technology, particularly in the development of highly accurate blood biomarker tests. This type of diagnostic tool leverages specific biomarkers found in the blood to detect diseases or monitor health conditions, thus ensuring remarkable precision and dependability. For example, Quanterix, a U.S. life sciences firm, unveiled a highly accurate blood biomarker test – LucentAD p-Tau 217 – in October 2023, designed to assist physicians in diagnosing Alzheimer’s disease in cognitively impaired adults. The test quantifies phosphorylated tau protein at threonine 217 (p-Tau 217), a biomarker closely tied to Alzheimer’s disease pathology, notably amyloid accumulation in the brain. With an efficacy of over 90%, the LucentAD p-Tau 217 test meets strict diagnostic standards and is devised to complement other diagnostic instruments rather than replace them.

Who Are The Primary Market Leaders In The Blood Based Biomarkers Market?

Major companies operating in the blood based biomarkers market are Siemens Healthineers AG, Agilent Technologies Inc, Eisai Co Ltd, Sysmex Corporation, Exact Sciences Corporation, Guardant Health, Quanterix Corporation, Illumina Inc, QIAGEN NV, GENFIT, Foundation Medicine Inc, Adaptive Biotechnologies Corporation, GRAIL LLC, Biodesix Inc, Cleveland Diagnostics Inc, Creative Diagnostics, Epigenomics AG, C2N Diagnostics, Diadem srl, Proteomedix AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/blood-based-biomarkers-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Blood Based Biomarkers Market?

North America was the largest region in the blood-based biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood based biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24176&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model